{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:55:50Z","timestamp":1777686950711,"version":"3.51.4"},"reference-count":54,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T00:00:00Z","timestamp":1753142400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"DOI":"10.13039\/100014605","name":"Sage Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Huntington's Disease"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Huntington's Disease (HD) Everyday Functioning (Hi-DEF) is a novel patient-reported outcome (PRO) scale developed to assess the impact of cognitive impairment on daily functioning in early HD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To examine the psychometric properties, including reliability and validity, of the Hi-DEF. Findings from psychometric analyses using classical test theory (CTT) approach are presented here.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A non-interventional validation study was conducted across nine HD Centers of Excellence across the US.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Patients with HD (n\u2009=\u2009151) were recruited: 59% were female, mean (SD) age was 47 (12) years, and mean (range) Total Functional Capacity (TFC) score was 11.4 (8\u201313). Excellent internal consistency reliability was observed for the Hi-DEF scale total score (Cronbach's alpha: 0.98) and across subscales (alpha range 0.87\u20130.96). Most targeting and scaling assumptions were met, although there were ceiling effects for three subscales. Construct validity was demonstrated by moderate to high Spearman's rank-order correlations with TFC scores (range r\u2009=\u2009\u22120.38 to \u22120.62) and known and validated measures such as the HD-PRO-TRIAD\n                      <jats:sup>TM<\/jats:sup>\n                      (range r\u2009=\u20090.75\u20130.90), and ability to discriminate between levels of functional impairment (TFC 13, 12\u201311, and 10\u20138;\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Correlations with Cambridge Neuropsychological Test Automated Battery (CANTAB) cognitive performance measures were low to moderate and ranged from 0.06 to 0.38.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The Hi-DEF is a reliable and valid PRO scale measuring the impact of cognitive impairment on daily functioning, assessing facets of cognitive functioning in context of activities of daily living impacted in early stages of HD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/18796397251358375","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T07:05:07Z","timestamp":1753167907000},"page":"369-381","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Reliability and validity of the Huntington's Disease Everyday Functioning (Hi-DEF): A patient-reported measure of cognitive capacity on daily functioning in Huntington's disease"],"prefix":"10.1177","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8441-2157","authenticated-orcid":false,"given":"Jennifer","family":"Petrillo","sequence":"first","affiliation":[{"name":"Sage Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruta","family":"Sawant","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-0140-7820","authenticated-orcid":false,"given":"Rebecca","family":"Rogers","sequence":"additional","affiliation":[{"name":"Modus Outcomes, a Division of THREAD, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sophie","family":"Cleanthous","sequence":"additional","affiliation":[{"name":"Modus Outcomes, a Division of THREAD, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-273X","authenticated-orcid":false,"given":"Stefan","family":"Cano","sequence":"additional","affiliation":[{"name":"Modus Outcomes, a Division of THREAD, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajeev","family":"Kumar","sequence":"additional","affiliation":[{"name":"Rocky Mountain Movement Disorders, Englewood, CO, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4943-1773","authenticated-orcid":false,"given":"Jennifer","family":"Klapper","sequence":"additional","affiliation":[{"name":"University of Pennsylvania Huntington's Disease Center, Philadelphia, PA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1932-5556","authenticated-orcid":false,"given":"Luis A","family":"Sierra","sequence":"additional","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Clinical Research Trials Excellence in Neurology (CORTEX), Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee","family":"Bang","sequence":"additional","affiliation":[{"name":"Johns Hopkins Medicine, Neurology, Baltimore, MD, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-6869","authenticated-orcid":false,"given":"Karen Elta","family":"Anderson","sequence":"additional","affiliation":[{"name":"Georgetown University, Department of Psychiatry &amp; Department of Neurology, Washington, DC, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah A","family":"Hall","sequence":"additional","affiliation":[{"name":"Rush University, Department of Neurological Sciences, Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Perlman","sequence":"additional","affiliation":[{"name":"University of California, Los Angeles, Department of Neurology, Los Angeles, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4398-5001","authenticated-orcid":false,"given":"Henry","family":"Moore","sequence":"additional","affiliation":[{"name":"University of Miami, Department of Neurology, Movement Disorders Division, Miami, FL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danny","family":"Bega","sequence":"additional","affiliation":[{"name":"Northwestern Medicine, Neurology (Movement Disorders), Chicago, IL, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7049-4873","authenticated-orcid":false,"given":"Jason","family":"Johannesen","sequence":"additional","affiliation":[{"name":"Sage Therapeutics, Inc., Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4323-9308","authenticated-orcid":false,"given":"Emma","family":"Elliott","sequence":"additional","affiliation":[{"name":"Modus Outcomes, a Division of THREAD, Cambridge, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,7,22]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2021-003074"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-78790-5"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.536"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2022-329812"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.13975"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2015.12.018"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1080\/09638288.2020.1783001"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-74985-9_18"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.5498\/wjp.v3.i3.62"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/B978-1-4160-3370-7.00055-9"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13413"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000008906"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-160228"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-023-11823-x"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-220555"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(22)00120-X"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.3009"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2013-305114"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.178"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01748.x"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1371\/currents.RRN1254"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.98.18_supplement.2666"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.5334\/tohm.177"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-016-1386-3"},{"key":"e_1_3_4_26_2","first-page":"870","article-title":"Functional rating scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington\u2019s disease: the importance of the patient voice in scale development [abstract]","volume":"37","author":"Fuller R","year":"2022","unstructured":"Fuller R, Feigenbaum P, Lapelle N, et al. Functional rating scale 2.0 (FuRST2.0), a patient reported outcome measure for Huntington\u2019s disease: the importance of the patient voice in scale development [abstract]. Mov Disord 2022; 37: 870.","journal-title":"Mov Disord"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2151"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/18796397241289044"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.3233\/JHD-240001"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2307\/1412159"},{"key":"e_1_3_4_31_2","unstructured":"US Food and Drug Administration. Patient reported outcome measures: use in medical product development to support labelling claim http:\/\/www.fda.gov\/downloads\/Drugs\/Guidances\/UCM193282.pdf (2009)."},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199604)11:4<329::AID-GPS453>3.0.CO;2-6"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcad043"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-324104"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF01593882"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00422218"},{"key":"e_1_3_4_37_2","volume-title":"Scale development: Theory and applications","author":"DeVellis RF","year":"2021","unstructured":"DeVellis RF, Thorpe CT. Scale development: Theory and applications. Fifth ed. Thousand Oaks, CA: Sage Publications, 2021."},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3758\/BF03203140"},{"key":"e_1_3_4_39_2","first-page":"55","article-title":"A technique for the measurement of attitudes","volume":"22","author":"Likert R","year":"1932","unstructured":"Likert R. A technique for the measurement of attitudes. Arch Psychol 1932; 22: 55.","journal-title":"Arch Psychol"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005650-199401000-00004"},{"key":"e_1_3_4_41_2","first-page":"997","volume-title":"MAP-R for windows: multitrait\/multi-item analysis program\u2014revised user\u2019s guide","author":"Ware J","year":"1997","unstructured":"Ware J, Harris W, Gandek B, et al. MAP-R for windows: multitrait\/multi-item analysis program\u2014revised user\u2019s guide, vol. 1. Boston, MA: Health Assessment Lab, 1997, p.997."},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02310555"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/1478-7954-7-18"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.3310\/hta8090"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2011.06.013"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1177\/1352458512462919"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.697234"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.2.452"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.knee.2015.04.002"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1080\/13803395.2023.2213847"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2923-2"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2010.01.012"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.intell.2024.101869"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25964"},{"key":"e_1_3_4_55_2","volume-title":"CHDI Foundation 2023 Huntington\u2019s Disease Therapeutics Conference","author":"Petrillo J","year":"2023","unstructured":"Petrillo J, Elliott E, Cleanthous S, et al. Huntington\u2019s disease everyday functioning \u2013 short form (Hi-DEF-SF) scale: Validation analyses results. In: CHDI Foundation 2023 Huntington\u2019s Disease Therapeutics Conference, Dubrovnik, Croatia, 24\u201327 April 2023."}],"container-title":["Journal of Huntington's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/18796397251358375","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/18796397251358375","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/18796397251358375","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T08:56:37Z","timestamp":1777452997000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/18796397251358375"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,22]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/18796397251358375"],"URL":"https:\/\/doi.org\/10.1177\/18796397251358375","relation":{},"ISSN":["1879-6397","1879-6400"],"issn-type":[{"value":"1879-6397","type":"print"},{"value":"1879-6400","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,22]]}}}